A prospective and randomised trial of efficacy and safety of transdermal oxybutynin versus oral oxybutynin in the management of children with overactive bladder
Main Authors: | A.H. Sevinç, A. Şahan, O. Özkaptan, A. Çubuk, A. Kafkaslı, C. Çanakçı, O. Telli |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320333504 |
Similar Items
-
An update on the use of transdermal oxybutynin in the management of overactive bladder disorder
by: Joshua A. Cohn, et al.
Published: (2016-04-01) -
Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin
by: Tondalaya Gamble, et al.
Published: (2008-11-01) -
Insights into the Management of Overactive Bladder with Transdermal Oxybutynin: A Practical Review
by: Vozmediano-Chicharro R, et al.
Published: (2020-08-01) -
Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain
by: Carlos Crespo, et al. -
Efficacy of Transdermal Oxybutynin in the Treatment of Overactive Bladder Syndrome: Does It Make Sense Using It in 2017?
by: Raúl Vozmediano-Chicharro, et al.
Published: (2018-01-01)